Related Experiment Video
Updated: May 30, 2026
05:37
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
Age-related susceptibility to hepatotoxicants
1University of Oklahoma Health Sciences Center, College of Pharmacy, P.O. Box 26901, Oklahoma City, OK 73190, USA.
Environmental Toxicology and Pharmacology
|July 26, 2011
Summary
Aging alters liver vulnerability to toxic chemicals. Mechanisms vary by chemical, with some linked to metabolic changes and others, like diquat, to increased iron content in older rats. Further research is needed.
Area of Science:
- Toxicology
- Hepatology
- Aging Research
Background:
- Limited understanding exists on how aging affects susceptibility to liver-damaging chemicals.
- Age-related changes in liver vulnerability can be chemical-specific.
Purpose of the Study:
- To explore age-associated mechanisms influencing liver injury from chemical exposure.
- To investigate how aging impacts the liver's response to toxicants like allyl alcohol, carbon tetrachloride, and diquat.
Main Methods:
- Comparative analysis of liver damage severity in young-adult versus old rats exposed to specific chemicals.
- Investigation of metabolic activation/detoxification pathways and cellular iron content in relation to age and toxicity.
Main Results:
- For allyl alcohol, age-associated liver damage severity correlates with altered liver biotransformation enzyme activity.
- For carbon tetrachloride, aging's effect on liver injury severity is not linked to activation/detoxification process changes.
- Increased hepatocyte iron content in old rats appears to explain heightened diquat toxicity compared to young rats.
Conclusions:
- Mechanisms underlying age-dependent differences in chemical-induced liver injury are diverse and chemical-specific.
- Metabolic alterations and increased iron content are potential age-related factors contributing to liver toxicity.
- Further investigation is required to fully elucidate the mechanisms of age-related chemical sensitivity in the liver.
Related Concept Videos
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...